.GAMMA.-CYCLODEXTRIN, 6A,6B,6C,6D,6E,7F,6G,6H-OCTAKIS-S-(2-CARBOXYETHYL)-6A,6B,6C,6D,6E,7F,6G,6H-OCTATHIO-
Pharmacokinetics
Guangzhou General Hospital of Guangzhou Military CommandSmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Pharmacokinetics cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Trimethoprim Texas Tech University Health Sciences Center | Phase 4 | BB |
SULFAMETHOXAZOLE Texas Tech University Health Sciences Center | Phase 4 | BB |
Gemtuzumab Ozogamicin Pfizer | Phase 4 | BB |
Human Plasma-Derived Coagulation Factor Viii Concentrate Beijing Children's Hospital | Phase 4 | BB |
Valproic Acid Northwell Health | Phase 4 | BB |
View all 30 →
Same molecule, other indications
.GAMMA.-CYCLODEXTRIN, 6A,6B,6C,6D,6E,7F,6G,6H-OCTAKIS-S-(2-CARBOXYETHYL)-6A,6B,6C,6D,6E,7F,6G,6H-OCTATHIO- is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →